Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis

Fermentanomics is an emerging field of research and involves understanding the underlying controlled process variables and their effect on process yield and product quality. Although major advancements have occurred in process analytics over the past two decades, accurate real‐time measurement of significant quality attributes for a biotech product during production culture is still not feasible. Researchers have used an amalgam of process models and analytical measurements for monitoring and process control during production. This article focuses on using multivariate data analysis as a tool for monitoring the internal bioreactor dynamics, the metabolic state of the cell, and interactions among them during culture. Quality attributes of the monoclonal antibody product that were monitored include glycosylation profile of the final product along with process attributes, such as viable cell density and level of antibody expression. These were related to process variables, raw materials components of the chemically defined hybridoma media, concentration of metabolites formed during the course of the culture, aeration‐related parameters, and supplemented raw materials such as glucose, methionine, threonine, tryptophan, and tyrosine. This article demonstrates the utility of multivariate data analysis for correlating the product quality attributes (especially glycosylation) to process variables and raw materials (especially amino acid supplements in cell culture media). The proposed approach can be applied for process optimization to increase product expression, improve consistency of product quality, and target the desired quality attribute profile. © 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:1586–1599, 2015

[1]  T. Raju,et al.  Terminal sugars of Fc glycans influence antibody effector functions of IgGs. , 2008, Current opinion in immunology.

[2]  Pradip K. Roychoudhury,et al.  Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell , 2013, Cytotechnology.

[3]  Abhinav A Shukla,et al.  Recent advances in large-scale production of monoclonal antibodies and related proteins. , 2010, Trends in biotechnology.

[4]  Scott A. Bradley,et al.  Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy. , 2010, Journal of the American Chemical Society.

[5]  B. Shah,et al.  Comparison of N‐Linked Oligosaccharides of Recombinant Human Tissue Kallikrein Produced by Chinese Hamster Ovary Cells on Microcarrier Beads and in Serum‐Free Suspension Culture , 1994, Biotechnology progress.

[6]  Takeshi Kobayashi,et al.  Effects of Oxygen Aeration on Production of Monoclonal Antibody in Immobilized Hybridoma-Cell Bioreactor , 1990 .

[7]  Anurag S. Rathore,et al.  Chemometrics applications in biotech processes: Assessing process comparability , 2012, Biotechnology progress.

[8]  John R. Engen,et al.  Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.

[9]  S Vaidyanathan,et al.  Assessment of near-infrared spectral information for rapid monitoring of bioprocess quality. , 2001, Biotechnology and bioengineering.

[10]  T. Raju,et al.  Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. , 2000, Glycobiology.

[11]  Anurag S Rathore,et al.  Chemometrics applications in biotechnology processes: Predicting column integrity and impurity clearance during reuse of chromatography resin , 2012, Biotechnology progress.

[12]  P. Parren,et al.  Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. , 2008, Blood.

[13]  Ali Cinar,et al.  Statistical monitoring of multistage, multiphase batch processes , 2002 .

[14]  A. Bull,et al.  Monitoring recombinant human interferon‐gamma N‐glycosylation during perfused fluidized‐bed and stirred‐tank batch culture of CHO cells , 1998, Biotechnology and bioengineering.

[15]  Wei-Shou Hu,et al.  Cell culture technology for pharmaceutical and cell-based therapies , 2005 .

[16]  M. Butler,et al.  Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. , 2000, Biotechnology and bioengineering.

[17]  M. Butler,et al.  The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. , 1997, Biotechnology and bioengineering.

[18]  M M Alvarez,et al.  Use of a Plackett–Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells , 2011, Biotechnology progress.

[19]  Michael Butler,et al.  Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals , 2005, Applied Microbiology and Biotechnology.

[20]  M. Butler,et al.  Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.

[21]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[22]  C. Goochee,et al.  The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.

[23]  M. Moo-young,et al.  Statistical methods in media optimization for batch and fed-batch animal cell culture , 2007, Bioprocess and biosystems engineering.

[24]  Arushi Arora,et al.  Guidance for performing multivariate data analysis of bioprocessing data: Pitfalls and recommendations , 2014, Biotechnology progress.

[25]  D. Burton,et al.  Sugar Determines Antibody Activity , 2006, Science.

[26]  Anurag S Rathore,et al.  Application of near‐infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein , 2009, Biotechnology progress.

[27]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[28]  Nigel Jenkins,et al.  Effect of lipid supplements on the production and glycosylation of recombinant interferon-γ expressed in CHO cells , 2004, Cytotechnology.

[29]  D. Bracewell,et al.  Impact of aeration strategy on CHO cell performance during antibody production , 2013, Biotechnology progress.

[30]  Gyun Min Lee,et al.  Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. , 2003, Biotechnology and bioengineering.

[31]  Theodora Kourti,et al.  Comparing alternative approaches for multivariate statistical analysis of batch process data , 1999 .

[32]  H. Gabius,et al.  The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Hoy,et al.  Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.

[34]  R. Wagner,et al.  Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. , 1999, Biotechnology and bioengineering.

[35]  L. S. Young,et al.  Effect of process change from perfusion to fed-batch on product comparability for biosimilar monoclonal antibody , 2012 .

[36]  Jarka Glassey,et al.  An assessment of seed quality and its influence on productivity estimation in an industrial antibiotic fermentation. , 2002, Biotechnology and bioengineering.

[37]  Mariana Henriques,et al.  Glycosylation: impact, control and improvement during therapeutic protein production , 2014, Critical reviews in biotechnology.

[38]  J. Engasser,et al.  Influence of amino acids on hybridoma cell viability and antibody secretion , 1989, Cytotechnology.

[39]  F. Gòdia,et al.  Analysis of Nutritional Factors and Physical Conditions Affecting Growth and Monoclonal Antibody Production of the Hybridoma KB‐26.5 Cell Line , 1996, Biotechnology progress.

[40]  F. Regnier,et al.  Rapid process monitoring in biotechnology. , 1993, Trends in biotechnology.

[41]  Anurag S. Rathore,et al.  Chemometrics application in biotech processes: assessing comparability across processes and scales , 2014 .

[42]  A. Rathore,et al.  Application of Multivariate Data Analysis for Identification and Successful Resolution of a Root Cause for a Bioprocessing Application , 2008, Biotechnology progress.

[43]  C. Goochee,et al.  The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. , 1994, Current opinion in biotechnology.

[44]  C. Agarabi,et al.  Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture , 2013, Biotechnology progress.

[45]  P. V. van Berkel,et al.  Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.

[46]  M. Butler,et al.  Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.

[47]  H. Gabius,et al.  The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acidα2,6GalNAc , 2005 .